KEZAR LIFE SCIENCES, INC.Stock Option Agreement • May 24th, 2018 • Kezar Life Sciences, Inc. • Pharmaceutical preparations • Delaware
Unless otherwise defined herein, the terms defined in the 2015 Equity Incentive Plan (the “Plan”) shall have the same defined meanings in this Stock Option Agreement – Early Exercise (the “Option Agreement”).
EXCLUSIVE LICENSE AGREEMENT by and between ONYX THERAPEUTICS, INC. and KEZAR LIFE SCIENCES, INC. Dated as of June 11, 2015Exclusive License Agreement • May 24th, 2018 • Kezar Life Sciences, Inc. • Pharmaceutical preparations • California
This EXCLUSIVE LICENSE AGREEMENT (this “Agreement”) is entered into as of June 11, 2015 (the “Effective Date”) by and between ONYX THERAPEUTICS, INC., a Delaware corporation having an address at 249 E. Grand Avenue, South San Francisco, CA 94080 (“ONYX”), and KEZAR LIFE SCIENCES, INC., a Delaware corporation having an address at 391 Carl Street, San Francisco, CA 94117 (“KEZAR”). KEZAR and ONYX are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
KEZAR LIFE SCIENCES, INC.Stock Option Agreement • May 24th, 2018 • Kezar Life Sciences, Inc. • Pharmaceutical preparations • Delaware
Unless otherwise defined herein, the terms defined in the 2015 Equity Incentive Plan (the “Plan”) shall have the same defined meanings in this Stock Option Agreement (the “Option Agreement”).
